This is a commercialization
rerating case, not a full-fleet-in-service case. If NuScale lands one binding U.S. package, keeps Romania on a credible path, and attaches services to each site, investors can value it as a de-risking nuclear platform instead of a concept stock. The upside is meaningful, but the need for signed projects and likely
dilution keeps it below true hypergrowth territory.